CRBP — Corbus Pharmaceuticals Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $95.29m
- -$53.77m
Annual cashflow statement for Corbus Pharmaceuticals Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -111 | -45.6 | -42.3 | -44.6 | -40.2 |
| Depreciation | |||||
| Non-Cash Items | 13.7 | 12.2 | 8.06 | 4.59 | 4.33 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.2 | -15.7 | -4.02 | 3.27 | -6.51 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -99.7 | -48.2 | -37.5 | -36.1 | -41.8 |
| Capital Expenditures | -0.484 | -0.054 | -0.013 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -73.4 | 30.1 | 35.6 | -121 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.484 | -73.4 | 30.1 | 35.6 | -121 |
| Financing Cash Flow Items | -6.04 | -1.82 | 0 | -0.191 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 155 | 60.8 | -0.534 | -2.82 | 167 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 54.7 | -60.8 | -8 | -3.28 | 3.47 |